Harris Poll Survey Finds People Receiving Treatment for CIDP Are Interested in Exploring More Convenient Treatment Options

/PRNewswire/ -- CSL Behring, a business unit of global biotechnology leader CSL, today announced survey results showing that the majority of surveyed people...

Related Keywords

United States ,Melbourne ,Victoria ,Australia ,America ,Bob Lojewski ,Demyelinating Polyneuropathy ,Behring Hizentra ,Etanjalie Ayala ,Jeffrey Allen ,Behring Pharmacovigilance Department ,Twitter ,University Of Minnesota Medical School ,Harris Poll ,Minnesota Medical ,Immune Globulin Subcutaneous ,Senior Vice President ,General Manager ,North America ,Chronic Inflammatory Demyelinating Polyneuropathy ,Safety Information ,Pharmacovigilance Department ,Csl Behring ,